Previous Close | 16.17 |
Open | 16.20 |
Bid | 16.34 x 1000 |
Ask | 16.35 x 1100 |
Day's Range | 16.12 - 16.37 |
52 Week Range | 7.88 - 16.88 |
Volume | |
Avg. Volume | 4,428,372 |
Market Cap | 8.06B |
Beta (5Y Monthly) | 1.30 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.50 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 17.70 |
Subscribe to Yahoo Finance Plus to view Fair Value for ELAN
Elanco Animal Health Inc (NYSE:ELAN), a company specializing in the development, manufacturing, and marketing of products for animal health and production, has reported an insider purchase filed with the SEC.
NORTHAMPTON, MA / ACCESSWIRE / March 5, 2024 / Elanco Animal Health CEO, Jeff Simmons joins Jim Cramer on Mad Money to discuss the company's commitment to create solutions for farmers and ranchers that can reduce, measure, and monetize greenhouse ...
Elanco Animal Health (NYSE: ELAN) announced today the appointment of Shiv O'Neill as the company's Executive Vice President, General Counsel and Corporate Secretary. O'Neill will be responsible for the global strategy and operations of the Company's legal team, ethics & compliance organization and ESG efforts.